To understand WM, it helps to know about the functions of lymphoid tissue in the body.
Lymphoid tissue and the immune system
Lymphoid tissue is made up several types of immune system cells that work together to help the body resist infections. Lymphoid tissue is found in many places in the body:
Lymph nodes, which are pea-sized collections of immune system cells throughout the body, including in the underarm area, in the groin, on the sides of the neck, and inside the chest and abdomen q Bone marrow, the soft inner part of certain bones where new blood cells are made q The thymus, a small organ behind the chest bone and in front of the heart q The spleen, an organ on the left side of the abdomen next to the stomach The WM cells grow mainly in the bone marrow, where they can crowd out the normal cells that make the different types of blood cells. This can lead to low levels of red blood cells (called anemia 4 ), which can make people feel tired and weak. It can also cause low numbers of white blood cells, which makes it hard for the body to fight infection. The numbers of platelets in the blood can also drop, leading to increased bleeding and bruising.
Lymphoma cells can also grow in organs like the liver and spleen, causing these organs to swell and leading to abdominal pain. (For more on the symptoms of WM, see Signs and Symptoms of Waldenstrom Macroglobulinemia 5 .)
Key Statistics About Waldenstrom Macroglobulinemia
Waldenstrom macroglobulinemia (WM) is rare, with an incidence rate of about 3 cases per million people per year in the United States. About 1,000 to 1,500 people are diagnosed with WM each year in the United States.
WM is more common in men than it is in women , and it is much more common among whites than African Americans.
There are few cases of WM in younger people, but the chance of developing this disease goes up as people get older. The average age of people when they are diagnosed with WM is 70 . 
Genetics
Scientists are making great progress in understanding how changes in DNA can cause normal lymphocytes to develop into WM cells. For example, in most people with WM, the cancer cells have been found to have changes in the MYD88 gene. More recently, a smaller percentage of WM cells have been found to have changes in the CXCR4 gene. Changes in these genes have been linked with a greater chance of WM causing symptoms and requiring treatment, and seem to affect survival as well. Researchers are now looking to develop drugs that can target cells with these gene changes. Some of these drugs are now in early clinical trials.
Chemotherapy and targeted therapies
Many new drugs to treat WM are being studied in clinical trials 4 , as well as ways to use drugs already known to be effective by combining them in new ways, using different doses, or different sequences of drugs, one after another. 
Biological therapy
Another newer approach to WM treatment is the use of biological response modifiersthat stimulate the patient's immune system to attack and destroy the lymphoma cells.
For example, it has recently been found that the bone marrow support tissues (stromal cells) make a substance called interleukin 6 (IL-6). IL-6 is a strong growth factor for multiple myeloma cells. IL-6 also helps cause the bone destruction seen in myeloma. Some current research efforts are trying to develop ways to block these functions of IL-6.
Bone marrow and peripheral blood stem cell transplant
Researchers are continually improving bone marrow and peripheral blood stem cell transplant methods 5 , as well as trying to determine how helpful this type of treatment can be for people with WM.
Vaccines
Doctors know it is possible for people with cancer to develop immune responses to their cancer. In rare instances, people's immune systems have rejected their cancers, and they have been cured. Scientists are now studying ways to boost this immune reaction by using vaccines.
Unlike vaccines used to prevent infections, these vaccines create an immune reaction against the lymphoma cells in patients who have very early disease or whose disease is in remission but could come back or relapse. This is a major area of research in treating
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